fbpx
QQQ
+ 2.19
278.28
+ 0.78%
DIA
-2.30
279.39
-0.83%
SPY
-1.15
340.63
-0.34%
TLT
+ 1.07
158.41
+ 0.67%
GLD
+ 0.53
178.00
+ 0.3%

PharmaCielo Announces Expansion In Latin America Through Veterinary CBD Partnership

August 16, 2019 2:19 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Canada-based PharmaCielo Ltd (OTC:PHCEF), one of the largest cannabis companies operating in Colombia, announced this week it's teaming up with Uruguay-based Laboratorios Adler to supply the latter with CBD isolate and oil extracts for veterinary use.

This is PharmaCielo’s first foray into the growing CBD-based animal treatment market, and gives the company a foothold in several Latin American countries including Uruguay, Paraguay, Bolivia and Southern Brazil.

As part of the sales agreement, PharmaCielo will also provide Adler with finished veterinarian products from Swiss-based Creso Pharma Ltd (OTC:COPHF), a company that develops, produces and distributes cannabis-based therapeutic products for humans and animals.

PharmaCielo recently announced plans to acquire Creso with the deal, pending shareholders’ vote, planned to close later in the fall.

“The agreement with Adler is a unique opportunity to expand PharmaCielo’s footprint in the Latin American market and specifically within the burgeoning CBD-based animal health treatment,” PharmaCielo CEO David Attard, told Benzinga. “This is a relatively untapped market that bears great growth and a healthy profit margin potential for early movers.”

Related Stories:

Front Range Bio Acquires Hemp Genomics Co. Steep Hill

US Company Completes First Ever Commercial Export Of Retail CBD Products To Mexico

Photo by Javier Hasse.


Related Articles

Cannabis Movers & Shakers: Blueberries, Harborside, HEXO, Christina Lake, RespireRx

Here is a summary of the latest leadership changes within the cannabis industry. Blueberries Parts Ways With CEO Camilo Villalba  read more

Cannabis Regulatory Update: S.D. Favors Legalization, Tenn. Senator Supports Medical Weed, Detroit Update

South Dakota is likely to legalize medical marijuana sales this November.  That’s according to a recent poll, in which 74% of respondents said they’ll vote in favor of a medical marijuana program for the Mount Rushmore State. read more

This Active Cannabis ETF Could Get A Biden-Harris High

In the world of exchange-traded funds, it's not surprising that cannabis funds are viewed as beneficiaries of former Vice President Joe Biden perhaps winning the White House. read more

Traders Have Rotated Into Big Multinational Companies On OTC Markets

One of the ways we gauge market sentiment is by looking at rotation—which areas of the market, traders and investors are most bullish or bearish on, and watching how those trends change over time.  We can track this by looking at price (the upward or downward pressure on an asset) as well as by volume (where the most attention is being paid).  read more

Flow Cannabis CEO On Post-Election Policy Hopes, Strategy On Heels Of Caldera Launch

Flow Cannabis Co. recently launched Caldera, a line of premium extracts, vape cartridges, oils, and concentrates defined by their purity, potency and flavor. read more